Exact Mass: 415.176

Exact Mass Matches: 415.176

Found 182 metabolites which its exact mass value is equals to given mass value 415.176, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Naltriben

Naltriben

C26H25NO4 (415.1783)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists

   

Rupatadine

13-chloro-2-{1-[(5-methylpyridin-3-yl)methyl]piperidin-4-ylidene}-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3(8),4,6,11,13-hexaene

C26H26ClN3 (415.1815)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Rupatadine is a second-generation tricyclic H1-antihistamine.

   

4,8-Methano-8aH-bisbenzofuro[3,2-e:2',3'-g]isoquinoline-1,8a-diol,7-(cyclopropylmethyl)-5,6,7,8,9,14b-hexahydro-, (4bS,8R,8aS,14bR)-

22-(cyclopropylmethyl)-11,14-dioxa-22-azaheptacyclo[13.9.1.0^{1,13}.0^{2,21}.0^{4,12}.0^{5,10}.0^{19,25}]pentacosa-4(12),5,7,9,15,17,19(25)-heptaene-2,16-diol

C26H25NO4 (415.1783)


   

Sabeluzole

1-{4-[(1,3-benzothiazol-2-yl)(methyl)amino]piperidin-1-yl}-3-(4-fluorophenoxy)propan-2-ol

C22H26FN3O2S (415.173)


C26170 - Protective Agent > C1509 - Neuroprotective Agent

   

Aclidinomycin A

Aclidinomycin A

C21H25N3O6 (415.1743)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(S)-2-((S)-3-(1H-Imidazol-4-yl)-2-((S)-pyrrolidine-2-carboxamido)Propanamido)-3-(4-hydroxyphenyl)Propanoic acid

(S)-2-((S)-3-(1H-Imidazol-4-yl)-2-((S)-pyrrolidine-2-carboxamido)Propanamido)-3-(4-hydroxyphenyl)Propanoic acid

C20H25N5O5 (415.1856)


   

Ala Asp Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Ala Asp Pro Asn

(3S)-3-[(2S)-2-aminopropanamido]-4-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C16H25N5O8 (415.1703)


   

Ala Asn Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Ala Asn Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C16H25N5O8 (415.1703)


   

Ala Pro Asp Asn

(3S)-3-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C16H25N5O8 (415.1703)


   

Ala Pro Asn Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]butanedioic acid

C16H25N5O8 (415.1703)


   

Asp Ala Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Asp Ala Pro Asn

(3S)-3-amino-3-{[(2S)-1-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}propanoic acid

C16H25N5O8 (415.1703)


   

Asp Gly Pro Gln

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-carboxypropanamido]acetyl}pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C16H25N5O8 (415.1703)


   

Asp Gly Gln Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Asp Asn Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Asp Asn Pro Ala

(3S)-3-amino-3-{[(2S)-3-carbamoyl-1-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}propanoic acid

C16H25N5O8 (415.1703)


   

Asp Pro Ala Asn

(3S)-3-amino-4-[(2S)-2-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C16H25N5O8 (415.1703)


   

Asp Pro Gly Gln

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}acetamido)-4-carbamoylbutanoic acid

C16H25N5O8 (415.1703)


   

Asp Pro Asn Ala

(3S)-3-amino-4-[(2S)-2-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C16H25N5O8 (415.1703)


   

Asp Pro Gln Gly

(3S)-3-amino-4-[(2S)-2-{[(1S)-3-carbamoyl-1-[(carboxymethyl)carbamoyl]propyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C16H25N5O8 (415.1703)


   

Asp Gln Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Asp Gln Pro Gly

(3S)-3-amino-3-{[(2S)-4-carbamoyl-1-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamoyl}propanoic acid

C16H25N5O8 (415.1703)


   

Glu Gly Asn Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-carboxybutanamido]acetamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Glu Gly Pro Asn

(4S)-4-amino-4-({2-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-2-oxoethyl}carbamoyl)butanoic acid

C16H25N5O8 (415.1703)


   

Glu Asn Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carbamoylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Glu Asn Pro Gly

(4S)-4-amino-4-{[(2S)-3-carbamoyl-1-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}butanoic acid

C16H25N5O8 (415.1703)


   

Glu Pro Gly Asn

(4S)-4-amino-5-[(2S)-2-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid

C16H25N5O8 (415.1703)


   

Glu Pro Asn Gly

(4S)-4-amino-5-[(2S)-2-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C16H25N5O8 (415.1703)


   

Gly Asp Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C16H25N5O8 (415.1703)


   

Gly Asp Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Gly Glu Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carboxybutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Gly Glu Pro Asn

(4S)-4-(2-aminoacetamido)-5-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C16H25N5O8 (415.1703)


   

Gly Gly Pro Trp

(2S)-2-{[(2S)-1-[2-(2-aminoacetamido)acetyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C20H25N5O5 (415.1856)


   

Gly Gly Trp Pro

(2S)-1-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C20H25N5O5 (415.1856)


   

Gly Asn Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Gly Asn Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C16H25N5O8 (415.1703)


   

Gly Pro Asp Gln

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carboxypropanamido]-4-carbamoylbutanoic acid

C16H25N5O8 (415.1703)


   

Gly Pro Glu Asn

(4S)-4-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C16H25N5O8 (415.1703)


   

Gly Pro Gly Trp

(2S)-2-(2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}acetamido)-3-(1H-indol-3-yl)propanoic acid

C20H25N5O5 (415.1856)


   

Gly Pro Asn Glu

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]pentanedioic acid

C16H25N5O8 (415.1703)


   

Gly Pro Gln Asp

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]butanedioic acid

C16H25N5O8 (415.1703)


   

Gly Pro Trp Gly

2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]acetic acid

C20H25N5O5 (415.1856)


   

Gly Gln Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Gly Gln Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C16H25N5O8 (415.1703)


   

Gly Trp Gly Pro

(2S)-1-{2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]acetyl}pyrrolidine-2-carboxylic acid

C20H25N5O5 (415.1856)


   

Gly Trp Pro Gly

2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}acetic acid

C20H25N5O5 (415.1856)


   
   
   
   
   
   
   
   

Asn Ala Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Asn Ala Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C16H25N5O8 (415.1703)


   

Asn Asp Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Asn Asp Pro Ala

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-4-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C16H25N5O8 (415.1703)


   

Asn Glu Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carboxybutanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Asn Glu Pro Gly

(4S)-4-[(2S)-2-amino-3-carbamoylpropanamido]-5-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid

C16H25N5O8 (415.1703)


   

Asn Gly Glu Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Asn Gly Pro Glu

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetyl}pyrrolidin-2-yl]formamido}pentanedioic acid

C16H25N5O8 (415.1703)


   

Asn Pro Ala Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]butanedioic acid

C16H25N5O8 (415.1703)


   

Asn Pro Asp Ala

(3S)-3-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C16H25N5O8 (415.1703)


   

Asn Pro Glu Gly

(4S)-4-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-[(carboxymethyl)carbamoyl]butanoic acid

C16H25N5O8 (415.1703)


   

Asn Pro Gly Glu

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)pentanedioic acid

C16H25N5O8 (415.1703)


   

Pro Ala Asp Asn

(3S)-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-3-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanoic acid

C16H25N5O8 (415.1703)


   

Pro Ala Asn Asp

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanedioic acid

C16H25N5O8 (415.1703)


   

Pro Asp Ala Asn

(3S)-3-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C16H25N5O8 (415.1703)


   

Pro Asp Gly Gln

(2S)-4-carbamoyl-2-{2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}butanoic acid

C16H25N5O8 (415.1703)


   

Pro Asp Asn Ala

(3S)-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C16H25N5O8 (415.1703)


   

Pro Asp Gln Gly

(3S)-3-{[(1S)-3-carbamoyl-1-[(carboxymethyl)carbamoyl]propyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C16H25N5O8 (415.1703)


   

Pro Glu Gly Asn

(4S)-4-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C16H25N5O8 (415.1703)


   

Pro Glu Asn Gly

(4S)-4-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C16H25N5O8 (415.1703)


   

Pro Gly Asp Gln

(2S)-4-carbamoyl-2-[(2S)-3-carboxy-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]butanoic acid

C16H25N5O8 (415.1703)


   

Pro Gly Glu Asn

(4S)-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-4-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanoic acid

C16H25N5O8 (415.1703)


   

Pro Gly Gly Trp

(2S)-3-(1H-indol-3-yl)-2-(2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}acetamido)propanoic acid

C20H25N5O5 (415.1856)


   

Pro Gly Asn Glu

(2S)-2-[(2S)-3-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]pentanedioic acid

C16H25N5O8 (415.1703)


   

Pro Gly Gln Asp

(2S)-2-[(2S)-4-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]butanedioic acid

C16H25N5O8 (415.1703)


   

Pro Gly Trp Gly

2-[(2S)-3-(1H-indol-3-yl)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]acetic acid

C20H25N5O5 (415.1856)


   

Pro Asn Ala Asp

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanedioic acid

C16H25N5O8 (415.1703)


   

Pro Asn Asp Ala

(3S)-3-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C16H25N5O8 (415.1703)


   

Pro Asn Glu Gly

(4S)-4-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C16H25N5O8 (415.1703)


   

Pro Asn Gly Glu

(2S)-2-{2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}pentanedioic acid

C16H25N5O8 (415.1703)


   

Pro Gln Asp Gly

(3S)-3-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C16H25N5O8 (415.1703)


   

Pro Gln Gly Asp

(2S)-2-{2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}butanedioic acid

C16H25N5O8 (415.1703)


   

Pro Trp Gly Gly

2-{2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}acetic acid

C20H25N5O5 (415.1856)


   

Gln Asp Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Gln Asp Pro Gly

(3S)-3-[(2S)-2-amino-4-carbamoylbutanamido]-4-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-4-oxobutanoic acid

C16H25N5O8 (415.1703)


   

Gln Gly Asp Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

Gln Gly Pro Asp

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetyl}pyrrolidin-2-yl]formamido}butanedioic acid

C16H25N5O8 (415.1703)


   

Gln Pro Asp Gly

(3S)-3-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-[(carboxymethyl)carbamoyl]propanoic acid

C16H25N5O8 (415.1703)


   

Gln Pro Gly Asp

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)butanedioic acid

C16H25N5O8 (415.1703)


   
   
   
   
   
   

Trp Gly Gly Pro

(2S)-1-(2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}acetyl)pyrrolidine-2-carboxylic acid

C20H25N5O5 (415.1856)


   

Trp Gly Pro Gly

2-{[(2S)-1-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetyl}pyrrolidin-2-yl]formamido}acetic acid

C20H25N5O5 (415.1856)


   

Trp Pro Gly Gly

2-(2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}acetamido)acetic acid

C20H25N5O5 (415.1856)


   

HoPhe-Lys-OH

(S)-7-amino-2-(4-nitro-3-phenethoxybenzamido)heptanoic acid

C21H25N3O6 (415.1743)


   

Lys-HoPhe-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-5-phenylpentanoic acid

C21H25N3O6 (415.1743)


   

16-carboxy-17,18,19,20-tetranor-leukotriene E3

(5Z,7E,9E,11R,12S)-11-(L-cystein-S-yl)-12-hydroxyhexadeca-5,7,9-trienedioic acid;(5Z,7E,9E,11R,12S)-11-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-12-hydroxyhexadeca-5,7,9-trienedioic acid

C19H29NO7S (415.1665)


An icosanoid that is leukotriene E4 in which the non-conjugated double bond has been reduced to a single bond and four methylene groups have been lost from the resulting carboxyalkyl chain.

   

Benzeneethanol, 4-[1-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-1-methylethyl]-, 4-methylbenzenesulfonate (ester)

Benzeneethanol, 4-[1-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-1-methylethyl]-, 4-methylbenzenesulfonate (ester)

C23H29NO4S (415.1817)


   

(S)-2-TERT-BUTOXYCARBONYLAMINO-3-[4-(DIETHOXY-PHOSPHORYLMETHYL)-PHENYL]-PROPIONIC ACID

(S)-2-TERT-BUTOXYCARBONYLAMINO-3-[4-(DIETHOXY-PHOSPHORYLMETHYL)-PHENYL]-PROPIONIC ACID

C19H30NO7P (415.176)


   

(R)-4-(FMOC-AMINO)-5-PHENYLPENTANOIC ACI

(R)-4-(FMOC-AMINO)-5-PHENYLPENTANOIC ACI

C26H25NO4 (415.1783)


   

(S)-3-(4-ACETYLPHENYL)-4-ISOPROPYLOXAZOLIDIN-2-ONE

(S)-3-(4-ACETYLPHENYL)-4-ISOPROPYLOXAZOLIDIN-2-ONE

C26H25NO4 (415.1783)


   

Fmoc-(R)-3-Amino-5-phenylpentanoic acid

Fmoc-(R)-3-Amino-5-phenylpentanoic acid

C26H25NO4 (415.1783)


   

Fmoc-(S)-3-Amino-5-phenylpentanoic acid

Fmoc-(S)-3-Amino-5-phenylpentanoic acid

C26H25NO4 (415.1783)


   

fmoc-(s)-3-amino-4-(4-methyl-phenyl)-butyric acid

fmoc-(s)-3-amino-4-(4-methyl-phenyl)-butyric acid

C26H25NO4 (415.1783)


   

fmoc-(r)-3-amino-4-(2-methyl-phenyl)-butyric acid

fmoc-(r)-3-amino-4-(2-methyl-phenyl)-butyric acid

C26H25NO4 (415.1783)


   

Fmoc-(R)-3-Amino-4-(3-methylphenyl)-butyric acid

Fmoc-(R)-3-Amino-4-(3-methylphenyl)-butyric acid

C26H25NO4 (415.1783)


   

Fmoc-(R)-3-Amino-4-(4-methylphenyl)-butyric acid

Fmoc-(R)-3-Amino-4-(4-methylphenyl)-butyric acid

C26H25NO4 (415.1783)


   

Fmoc-(S)-3-Amino-4-(2-methylphenyl)-butyric acid

Fmoc-(S)-3-Amino-4-(2-methylphenyl)-butyric acid

C26H25NO4 (415.1783)


   

Fmoc-L-2-Amino-5-phenyl-pentanoic acid

Fmoc-L-2-Amino-5-phenyl-pentanoic acid

C26H25NO4 (415.1783)


   

fmoc-(s)-3-amino-4-(3-methyl-phenyl)-butyric acid

fmoc-(s)-3-amino-4-(3-methyl-phenyl)-butyric acid

C26H25NO4 (415.1783)


   

Donetidine

2-({2-[({5-[(Dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl} amino)-5-[(2-oxo-1,2-dihydro-3-pyridinyl)methyl]-4(3H)-pyrimidino ne

C20H25N5O3S (415.1678)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist

   

Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-phenyl-N-(3-pyridinylmethyl)- (9CI)

Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-phenyl-N-(3-pyridinylmethyl)- (9CI)

C24H25N5S (415.1831)


   

fmoc-d-2-amino-5-phenyl-pentanoic acid

fmoc-d-2-amino-5-phenyl-pentanoic acid

C26H25NO4 (415.1783)


   

Rizatriptan IMpurity A

Rizatriptan IMpurity A

C20H25N5O5 (415.1856)


   

N-([1,1-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine

N-([1,1-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine

C27H21N5 (415.1797)


ML228 (CID-46742353) is a potent the Hypoxia Inducible Factor (HIF) pathway activator with EC50 of 1 μM. ML228 potently activates HIF in vitro as well as its downstream target VEGF[1][2].

   

1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine Maleate

1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine Maleate

C23H29NO4S (415.1817)


   

5-[[4-(2-Amino-2-oxoethoxy)-3-methoxyphenyl]methylamino]-2-(4-morpholinyl)benzoic acid

5-[[4-(2-Amino-2-oxoethoxy)-3-methoxyphenyl]methylamino]-2-(4-morpholinyl)benzoic acid

C21H25N3O6 (415.1743)


   

H-Pro-his-tyr-OH

H-Pro-his-tyr-OH

C20H25N5O5 (415.1856)


   
   

(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]pyrimidin-4-YL}amino)phenoxy]-3-(dimethylamino)propan-2-OL

(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]pyrimidin-4-YL}amino)phenoxy]-3-(dimethylamino)propan-2-OL

C21H23F2N5O2 (415.182)


   

(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]pyrimidin-4-YL}amino)phenoxy]-3-(dimethylamino)propan-2-OL

(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]pyrimidin-4-YL}amino)phenoxy]-3-(dimethylamino)propan-2-OL

C21H23F2N5O2 (415.182)


   

Rupatadine

Rupatadine

C26H26ClN3 (415.1815)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

Sabeluzole

Sabeluzole

C22H26FN3O2S (415.173)


C26170 - Protective Agent > C1509 - Neuroprotective Agent

   

4,8-Methano-8aH-bisbenzofuro[3,2-e:2',3'-g]isoquinoline-1,8a-diol,7-(cyclopropylmethyl)-5,6,7,8,9,14b-hexahydro-, (4bS,8R,8aS,14bR)-

22-(cyclopropylmethyl)-11,14-dioxa-22-azaheptacyclo[13.9.1.0^{1,13}.0^{2,21}.0^{4,12}.0^{5,10}.0^{19,25}]pentacosa-4(12),5,7,9,15,17,19(25)-heptaene-2,16-diol

C26H25NO4 (415.1783)


   
   

Ala-Asn-Asp-Pro

Ala-Asn-Asp-Pro

C16H25N5O8 (415.1703)


A tetrapeptide composed of L-alanyl, L-asparagyl, L-aspartyl, and L-proline residues joined in sequence.

   

6-phenyl-N-[(3-phenylphenyl)methyl]-3-(2-pyridinyl)-1,2,4-triazin-5-amine

6-phenyl-N-[(3-phenylphenyl)methyl]-3-(2-pyridinyl)-1,2,4-triazin-5-amine

C27H21N5 (415.1797)


   

2-[(chloroacetyl)(4-methoxyphenyl)amino]-N-cyclohexyl-2-pyridin-3-ylacetamide

2-[(chloroacetyl)(4-methoxyphenyl)amino]-N-cyclohexyl-2-pyridin-3-ylacetamide

C22H26ClN3O3 (415.1663)


   

1-[3-[(7-Cyano-[1,3]dioxolo[4,5-g]quinolin-6-yl)amino]propyl]-3-(3-ethoxypropyl)thiourea

1-[3-[(7-Cyano-[1,3]dioxolo[4,5-g]quinolin-6-yl)amino]propyl]-3-(3-ethoxypropyl)thiourea

C20H25N5O3S (415.1678)


   

[2-(2,5-dimethylanilino)-2-oxoethyl] (E)-3-(2-methoxyphenyl)-2-phenylprop-2-enoate

[2-(2,5-dimethylanilino)-2-oxoethyl] (E)-3-(2-methoxyphenyl)-2-phenylprop-2-enoate

C26H25NO4 (415.1783)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Naltriben mesylate

Naltriben mesylate

C26H25NO4 (415.1783)


   
   
   

BC1618

BC1618

C24H24F3NO2 (415.1759)


BC1618, an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling (via preventing activated pAmpkα from Fbxo48-mediated degradation). BC1618 promotes mitochondrial fission, facilitates autophagy and improves hepatic insulin sensitivity[1].

   

12-hydroxy-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-6,9-diene-8,11-dione

12-hydroxy-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-6,9-diene-8,11-dione

C21H25N3O6 (415.1743)


   

(2s)-1-[(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

(2s)-1-[(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O8 (415.1703)


   

(3'ar,6'as)-2'-hydroxy-3,5-dimethoxy-3'a-[(4-methoxyphenyl)methyl]-6'a-(methylamino)-3',6'-dihydrospiro[cyclohexane-1,5'-furo[2,3-d]imidazole]-2,5-dien-4-one

(3'ar,6'as)-2'-hydroxy-3,5-dimethoxy-3'a-[(4-methoxyphenyl)methyl]-6'a-(methylamino)-3',6'-dihydrospiro[cyclohexane-1,5'-furo[2,3-d]imidazole]-2,5-dien-4-one

C21H25N3O6 (415.1743)


   

(1r,3r,12s,13s,18s,19s,21r,23r)-12-hydroxy-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-6,9-diene-8,11-dione

(1r,3r,12s,13s,18s,19s,21r,23r)-12-hydroxy-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-6,9-diene-8,11-dione

C21H25N3O6 (415.1743)


   

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[1-(hydroxymethyl)-6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-5-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[1-(hydroxymethyl)-6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-5-yl]oxy}oxane-3,4,5-triol

C19H29NO9 (415.1842)